IMMUNO-ONCOLOGY

• Target development
• Bispecifics
• CAR-T cell therapies
• Engineered B cells delivering genes
• AAV based therapies
• Development of NHP immunology models
• Immunogenicity and toxicity assessment in NHPs
• T cell activation biomarkers in monkeys
• Cell and gene therapy